week
administr
week
postinduct
incid
destruct
repair
antivegf
group
srcinhibit
group
supplement
inhibit
group
lower
control
group
wherea
higher
vegfsuppl
group
compar
control
group
howev
due
sampl
size
limit
differ
statist
signific
week
administr
week
postinduct
rabbit
control
group
domin
destruct
repair
wherea
rabbit
domin
destruct
repair
antivegf
group
srcinhibit
group
vegfsuppl
group
supplement
inhibit
group
respect
incid
destruct
repair
antivegf
group
srcinhibit
group
supplement
inhibit
group
significantli
lower
control
group
wherea
significantli
higher
vegfsuppl
group
compar
control
group
even
rabbit
show
domin
repar
osteogenesi
srcinhibit
group
supplement
inhibit
group
respect
repair
pattern
rest
rabbit
clearli
identifi
figur
trabecular
structur
osteonecrot
lesion
microct
measur
differ
quantiti
either
smallsiz
mm
larges
mm
trabecular
bone
antivegf
group
baselin
group
compar
baselin
less
larges
smallsiz
trabecular
bone
found
control
group
vegfsuppl
group
wherea
larges
less
smallsiz
trabecular
bone
found
srcinhibit
group
supplement
inhibit
group
appar
size
distribut
trabecula
shift
toward
thin
control
group
compar
baselin
shift
toward
thin
vegfsuppl
group
compar
control
group
wherea
hardli
shift
antivegf
group
shift
toward
moder
thicken
srcinhibit
group
supplement
inhibit
group
compar
baselin
figur
timecours
chang
dynam
vasculatur
function
index
shown
figur
vascular
index
peak
enhanc
percentag
pep
significantli
differ
pattern
pep
chang
time
vegfsuppl
group
supplement
inhibit
group
antivegf
group
compar
control
group
evidenc
twoway
repeat
measur
anova
p
interact
time
group
pep
vegfsuppl
group
supplement
inhibit
group
increas
continu
significantli
baselin
week
week
postadministr
vegfsuppl
group
supplement
inhibit
group
week
vegfsuppl
group
supplement
inhibit
group
week
p
decreas
continu
baselin
antivegf
group
week
week
postadministr
week
week
p
remain
almost
constant
control
group
increas
gradual
without
signific
srcinhibit
group
permeabl
index
permeabl
surfac
area
product
per
unit
volum
tissu
significantli
differ
pattern
chang
time
vegfsuppl
group
srcinhibit
group
supplement
inhibit
group
antvegf
group
compar
control
group
evidenc
gener
linear
model
glm
p
interact
time
group
srcinhibit
group
supplement
inhibit
group
antvegf
group
decreas
continu
significantli
baselin
week
week
postadministr
srcinhibit
group
supplement
inhibit
group
antvegf
group
week
srcinhibit
group
supplement
inhibit
group
antvegf
group
p
increas
continu
baselin
vegfsuppl
group
week
week
postadministr
week
week
p
remain
almost
constant
control
group
figur
figur
present
repres
angiogram
histogram
depict
size
angiograph
structur
control
group
show
larges
vessellik
structur
vl
surround
fewer
smallsiz
vl
mani
mediums
dissemin
leakag
structur
dlpl
antivegf
group
show
dilat
larges
vl
neither
smallsiz
vl
mediums
dlpl
srcinhibit
group
show
dilat
larges
vl
surround
smallsiz
vl
mediums
dlpl
compar
control
group
vegfsuppl
group
although
smallsiz
vl
also
mediums
dlpl
compar
control
supplement
inhibit
group
smallsiz
vl
nearli
mediums
dlpl
compar
control
group
figur
histogram
control
group
show
neither
continu
increas
smallsiz
vl
continu
decreas
dlpl
compar
baselin
continu
decreas
mediums
dlpl
administr
antivegf
group
srcinhibit
group
supplement
inhibit
group
found
similar
chang
pattern
continu
slight
increas
smallsiz
vl
administr
found
srcinhibit
group
continu
signific
increas
smallsiz
vl
administr
found
vegfsuppl
group
supplement
inhibit
group
wherea
continu
decreas
smallsiz
vl
found
antivegf
group
figur
figur
present
histomorphometri
marrow
circul
week
post
administr
includ
microvessel
densiti
mvd
edema
area
ea
leakag
particl
size
distribut
ea
antivegf
group
srcinhibit
group
supplement
inhibit
group
decreas
continu
significantli
similar
chang
pattern
baselin
administr
wherea
almost
remain
control
group
even
increas
continu
significantli
vegfsuppl
group
figur
mvd
antivegf
group
decreas
continu
significantli
baselin
administr
wherea
almost
maintain
control
group
increas
slightli
continu
srcinhibit
group
even
increas
continu
significantli
vegfsuppl
group
supplement
inhibit
group
figur
comparison
control
group
leakag
particl
less
found
antivegf
group
srcinhibit
group
supplement
inhibit
group
wherea
lot
leakag
particl
vegfsuppl
group
figur
phosphoryl
src
protein
express
antivegf
group
srcinhibit
group
supplement
inhibit
group
decreas
continu
significantli
baselin
similar
chang
pattern
administr
wherea
chang
control
group
significantli
increas
vegfsuppl
group
hand
total
src
express
level
remain
stabl
baselin
week
post
administr
show
differ
among
group
figur
studi
specif
investig
effect
src
inhibitor
vegf
mediat
vascular
hyperperm
bone
destruct
within
steroidassoci
osteonecrot
lesion
rabbit
lowlevel
marrow
stemcellpool
mscp
initi
osteonecrot
lesion
format
result
dynam
mri
perfus
function
index
microctbas
angiographi
histomorphometri
marrow
circul
consist
demonstr
antivegf
reduc
neovascular
permeabl
wherea
src
inhibitor
reduc
neovascular
reduc
permeabl
addit
immunoblot
phosphoryl
src
also
demonstr
significantli
decreas
src
level
srcinhibit
antivegf
supplement
inhibit
group
postadministr
time
point
taken
togeth
result
suggest
uncontrol
vegfsrc
signal
underli
observ
continu
increas
vascular
permeabl
inadequ
repair
steroidassoci
osteonecrosi
consist
recent
consensu
normal
vascular
turnov
requir
precis
spatiotempor
control
vegf
accordingli
encourag
use
select
blockad
strategi
src
signal
maintain
vegfmedi
angiogenesi
abolish
vegfmedi
permeabl
facilit
repair
histopatholog
result
lesion
classif
studi
show
antivegf
inhibit
destruct
repair
osteonecrot
lesion
format
evidenc
significantli
reduc
incid
destruct
repair
significantli
shift
size
distribut
curv
trabecular
thick
antivegf
group
compar
baselin
contrast
vegf
promot
destruct
repair
evidenc
incid
destruct
repair
moder
left
shift
size
distribut
curv
trabecular
thick
vegfsuppl
group
compar
control
vegf
chemoattract
osteoclast
induc
osteoclastogenesi
vitro
vivo
matrix
metalloproteas
mechan
similar
signal
pathway
involv
receptor
activ
nfkappab
ligand
rankl
data
suggest
potenti
link
uncontrol
vegf
signal
destruct
repair
steroidassoci
osteonecrot
lesion
test
therapeut
strategi
block
uncontrol
vegf
signal
challeng
tradit
held
opinion
enhanc
vegf
signal
might
augment
bone
repair
also
rais
emerg
concept
uncontrol
vegf
signal
could
induc
destruct
repair
mscp
continu
low
level
hand
studi
show
src
inhibitor
moder
promot
repar
osteogenesi
osteonecrot
lesion
format
evidenc
moder
increas
incid
repar
osteogenesi
moder
right
shift
size
distribut
curv
trabecular
thick
srcinhibit
supplement
inhibit
group
compar
control
could
explain
significantli
reduc
vascular
permeabl
caus
src
inhibitor
avoid
divert
blood
away
lesion
center
toward
peripheri
accordingli
facilit
deliveri
oxygen
nutrient
local
lesion
tissu
reconstruct
result
also
suggest
potenti
causal
relationship
continu
hyperperm
inact
repar
osteogenesi
test
therapeut
strategi
via
blockad
uncontrol
src
signal
time
use
src
inhibitor
modul
phosphoryl
src
express
level
examin
vascular
skelet
impact
intervent
tbutyl
pyrazolo
pyrimidin
cellperm
pyrazolopyrimidin
compound
inhibit
src
activ
dr
wei
et
al
use
block
src
phosphoryl
intraven
inject
drzan
et
al
inject
focal
cerebr
ischemia
rat
model
demonstr
effect
decreas
src
phosphoryl
level
reduc
vascular
permeabl
rat
present
studi
intraven
administr
dose
mgkg
accord
dose
convers
principl
among
differ
correspond
effect
dose
antiperm
previou
two
studi
efficaci
system
administr
also
verifi
studi
evidenc
significantli
decreas
phosphoryl
src
express
srcinhibit
group
supplement
inhibit
group
put
togeth
demonstr
supplement
inhibit
group
show
sound
repair
outcom
demonstr
lower
destruct
repair
incid
thicker
trabecular
structur
profil
better
neovascular
lower
permeabl
compar
control
group
suggest
supplement
vegf
inhibit
src
could
new
therapeut
strategi
steroidassoci
osteonecrot
patient
high
risk
subchondr
collaps
male
newzealand
white
rabbit
bodi
weight
kg
hous
anim
hous
institut
advanc
translat
medicin
bone
joint
diseas
hong
kong
baptist
univers
receiv
standard
laboratori
diet
water
ad
libitum
experiment
protocol
approv
anim
experi
ethic
committe
institut
advanc
translat
medicin
bone
joint
diseas
hong
kong
baptist
univers
ref
method
carri
accord
approv
guidelin
surgic
oper
offcial
approv
hong
kong
govern
ref
dhha
base
establish
protocol
induc
steroidassoci
osteonecrosi
rabbit
intraven
inject
bodi
weight
lipopolysaccharid
escherichia
coli
sigmaaldrich
usa
day
hour
three
inject
mgkg
bodi
weight
methylprednisolon
pharmacia
upjohn
usa
given
intramuscularli
interv
preinductionbaselin
week
induct
bone
marrow
aspir
iliac
crest
conduct
determin
size
marrow
stem
cell
pool
simscp
hematopoiet
mesenchym
compart
accord
publish
week
induct
rabbit
decreas
least
simscp
mesenchym
hematopoiet
compart
identifi
high
risker
progress
destruct
repair
within
osteonecrot
lesion
accord
publish
select
rabbit
system
administr
intraven
inject
either
antivegf
antibodi
recombin
human
monoclon
antivegf
mgkgtwo
week
antivegf
group
n
vegf
recombin
human
vegf
mgkgtwo
week
vegfsuppl
group
n
src
inhibitor
select
inhibitor
src
activ
nm
mgkgtwo
week
srcinhibit
group
n
combin
vegf
src
inhibitor
recombin
human
vegf
mgkgtwo
week
src
inhibitor
mgkgtwo
week
supplement
inhibit
group
n
control
vehicl
salin
control
group
n
week
six
rabbit
sacrif
baselin
administr
sampl
size
group
calcul
accord
publish
week
administr
vivo
dynam
mri
perform
proxim
femora
vascular
index
permeabl
index
respect
finish
dynam
mri
scan
euthanasia
also
execut
n
n
week
administr
group
bilater
proxim
femora
dissect
sacrific
follow
evalu
intraoss
vasculatur
includ
threedimension
angiographi
microct
twodimension
histomorphometri
marrow
circul
optic
microscopi
repair
pattern
osteonecrot
lesion
qualit
classifi
histopatholog
quantif
differenti
microct
local
phosphoryl
src
protein
express
quantifi
immunoblot
dynam
vascular
function
index
rabbit
anesthet
sodium
pentobarbit
mlkg
place
prone
posit
lower
limb
flex
mri
scan
use
superconduct
system
acsnt
intera
philip
medic
system
best
netherland
maximum
gradient
strength
mtm
bolu
dimeglumin
gadopentet
magnevist
schere
berlin
germani
mmolkgbodi
weight
rapidli
inject
automat
pump
link
previous
place
cathet
auditori
vein
dynam
mri
scan
perform
prescrib
plane
follow
paramet
short
gradient
echo
sequenc
trte
msec
flip
angl
slice
thick
mm
inplan
resolut
mm
averag
tempor
resolut
approxim
per
imag
acquisit
seri
dynam
imag
obtain
cover
washout
vascular
index
peak
enhanc
percentag
pep
permeabl
index
permeabl
surfac
area
product
per
unit
volum
tissu
accordingli
calcul
use
establish
gener
deep
anesthesia
sodium
pentobarbit
intraven
instil
mlkg
rabbit
abdomin
caviti
open
perfus
confect
radiopaqu
silicon
rubber
combin
neutral
buffer
formalin
heparin
normal
salin
uml
use
establish
trabecular
structur
osteonecrot
lesion
bilater
proxim
femor
sampl
quantif
differenti
microct
complet
decalcifi
proxim
femor
sampl
ethylenediaminetetraacet
acid
subject
microctbas
angiographi
thereaft
decalcifi
proxim
femur
embed
paraffin
section
thick
along
coron
plane
classifi
osteonecrot
lesion
repair
process
histomorphometri
marrow
circul
om
local
phosphoryl
src
express
immunoblot
respect
quantif
differenti
trabecular
structur
osteonecrot
lesion
proxim
part
bilater
undecalcifi
femor
sampl
taken
measur
trabecular
structur
osteonecrot
lesion
use
establish
histogram
gener
display
size
thick
distribut
trabecular
bone
colorcod
scale
map
surfac
imag
produc
visual
represent
size
distribut
trabecular
classif
osteonecrot
lesion
repair
classif
osteonecrot
lesion
repair
blindli
made
two
pathologist
use
om
aixoplan
spot
rt
digit
camera
zeiss
germani
osteonecrot
lesion
format
identifi
base
diffus
presenc
empti
lacuna
pyknot
nuclei
osteocyt
bone
trabecula
accompani
surround
bone
marrow
apposit
bone
format
osteoblastlik
cell
around
osteonecrot
lesion
classifi
repar
osteogenesi
wherea
granul
tissu
creep
link
necrot
bone
resorpt
classifi
destruct
repair
rabbit
domin
repar
osteogenesi
destruct
repair
term
unclassifi
microctbas
microangiographi
vascular
architectur
proxim
part
bilater
decalcifi
femor
sampl
taken
intraoss
microctbas
microangiographi
use
establish
histogram
gener
display
size
thick
distribut
angiograph
structur
colorcod
scale
map
surfac
imag
produc
visual
represent
size
distribut
angiograph
histomorphometri
marrow
circul
microvessel
densiti
mvd
fifteen
success
hematoxylin
section
everi
decalcifi
sampl
scan
initi
low
magnif
high
magnif
identifi
vascular
hotspot
use
optic
microscop
imag
system
zeiss
select
hotspot
adopt
standard
procedur
angiogenesi
studi
solid
neoplasm
hematolog
thought
area
increas
concentr
microvessel
may
repres
emerg
neoplast
clone
higher
angiogen
countabl
microvessel
outlin
trace
calcul
total
count
microvessel
per
total
examin
optic
field
success
section
bilater
decalcifi
femor
sampl
one
rabbit
microvessel
densiti
use
imag
analysi
softwar
imagej
nih
usa
edema
area
ea
histolog
section
scan
identifi
interstiti
marrow
edema
zone
om
section
four
randomli
select
field
left
right
examin
marrow
edema
zone
automat
trace
threshold
use
imagej
total
area
edema
zone
per
total
examin
optic
field
area
success
section
bilater
decalcifi
femor
sampl
edema
area
one
rabbit
calcul
accordingli
size
distribut
leakag
particl
section
examin
om
identifi
leakag
particl
region
correspond
scan
volum
interest
abovement
microctbas
microangiographi
easili
distinguish
black
radiopaqu
particl
perfus
angiograph
substanc
outsid
blood
vessel
defin
leakag
particl
leakag
particl
outlin
manual
trace
quantifi
area
perimet
use
imagej
base
stereolog
principl
bone
leakag
particl
size
calcul
follow
thick
areaperimet
histogram
display
size
distribut
leakag
particl
success
section
bilater
decalcifi
femor
sampl
one
rabbit
gener
use
excel
microsoft
usa
local
marrow
phosphoryl
src
protein
total
src
protein
express
immunoblot
marrow
tissu
harvest
lyse
homogen
ripa
lysi
buffer
unit
state
biolog
usa
homogen
precentrifug
g
min
collect
supernat
centrifug
g
h
protein
concentr
tissu
lysat
determin
bca
protein
assay
kit
pierc
usa
protein
heat
min
gelload
buffer
sigma
subject
sdspage
transfer
pvdf
membran
biorad
usa
use
transblot
sd
semidri
transfer
cell
biorad
block
defat
milk
h
membran
incub
primari
antibodi
ie
antisrc
biosourc
internationalusa
antisrc
biosourc
intern
usa
intern
control
overnight
follow
incub
secondari
antibodi
antigoat
igg
santa
cruz
biotechnolog
conjug
horseradish
peroxidas
h
protein
visual
chemiluminesc
ecl
plu
immunoblot
detect
system
pierc
total
src
express
normal
band
intens
use
molecular
imag
system
biorad
data
present
repres
least
three
separ
experi
statist
analysi
data
express
mean
sd
data
repeat
measur
mrideriv
vascular
function
index
analyz
twoway
repeat
measur
anova
data
nonrep
measur
includ
micro
vessel
densiti
edema
area
protein
express
level
analyz
oneway
analysi
varianc
post
hoc
multipl
comparison
test
studentnewmankeul
test
equal
varianc
assum
gameshowel
test
equal
varianc
assum
fisher
exact
probabl
test
perform
determin
differ
incid
data
repar
osteogenesi
destruct
repair
among
group
statist
analys
perform
use
spss
spss
chicago
il
usa
statist
signific
level
p
gz
apl
btz
design
studi
yxh
jl
bsg
yxw
xhp
dfl
tt
conduct
experi
yxh
jl
bsg
slp
analyz
data
yxh
jl
bsg
wrote
manuscript
gz
apl
btz
zcl
zxb
slp
yc
revis
manuscript
gz
apl
btz
approv
final
version
manuscript
took
respons
integr
data
